
Company Updates ·
Functional Brands lowers Series C preferred conversion price to $0.1636
The company agreed with all Series C holders to reset the conversion price to $0.1636 per share, the market price at signing.
MEHA Functional Brands Inc.

Company Updates ·
The company agreed with all Series C holders to reset the conversion price to $0.1636 per share, the market price at signing.
We have not published a story on Functional Brands yet. When there is news, it will appear here.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $6.6 million | $6.6 million |
| Net income (loss) | $758,478 | -$559,356 |
| Cash from operations | -$1.3 million | $1,990 |
| Cash and equivalents | $2.7 million | $211,642 |
Functional Brands Inc. trades under the ticker MEHA on OTC.
Functional Brands Inc. is listed on OTC.
Our directory records Functional Brands Inc. under United States.
aibio.space lists Functional Brands Inc. among 2,820 public biotech companies and publishes its news here as stories appear.
$6.6 million for the fiscal year ended Dec 31, 2025, as reported to the SEC.
Functional Brands Inc. reported net income of $758,478 for the fiscal year ended Dec 31, 2025, and used $1.3 million of cash in operations, per its annual report to the SEC.
$352,142 in cash at Jun 30, 2026, per its 10-Q.
Our latest story on Functional Brands, dated May 11, 2026: "Functional Brands lowers Series C preferred conversion price to $0.1636". The company agreed with all Series C holders to reset the conversion price to $0.1636 per share, the market price at signing. Source.
Press Follow on this page to add Functional Brands to your Following list, or subscribe to the aibio.space newsletter. We have published 1 story naming Functional Brands so far, in Company Updates.
Reported substantial doubt about its ability to continue as a going concern. SEC Form 10-Q. Source
Filed to remove its shares from exchange listing. SEC Form 25-NSE. Source
Reported the end of a material agreement. SEC Form 8-K (Items 1.02). Source
Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 3.01,7.01,9.01). Source
Reported a shareholder vote on a reverse stock split or more authorized shares. SEC Form 8-K (Items 5.07). Source
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction